Dr. Sachdev Sidhu: Restoring the Blood Retinal Barrier Clinical Trial
The blood-retinal barrier is important for proper retinal function and can be disturbed in eye diseases like AMD and diabetic retinopathy (DR) leading to vision loss. Dr. Sidhu has developed a new antibody treatment (EYE103) which has the potential to restore the blood retinal barrier and help improve vision for those with AMD or DR. With funding from Fighting Blindness Canada, Dr. Sidhu has now moved this treatment into a Phase 1 clinical trial to test if the potential treatment is safe.
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
